Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: India Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20111
20131
20221
20234
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Viatris Innovation GmbH2
Anthera Pharmaceuticals1
AstraZeneca1
Eli Lilly and Company1
Human Genome Sciences Inc.1
Human Genome Sciences Inc., a GSK Company1
Novartis Pharmaceuticals1
Pfizer1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases12
Lupus Erythematosus, Systemic8
Immune System Diseases6
Connective Tissue Diseases5
Arthritis, Rheumatoid1
Barth Syndrome1
Fatigue1
Joint Diseases1
Lung Diseases, Interstitial1
Neutropenia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.